GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 256 filers reported holding GW PHARMACEUTICALS PLC in Q2 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $139,205,000 | +226.0% | 641,796 | +73.5% | 0.02% | +166.7% |
| Q4 2020 | $42,699,000 | +17.7% | 369,974 | -0.7% | 0.01% | +20.0% |
| Q3 2020 | $36,268,000 | -18.1% | 372,562 | +3.3% | 0.01% | -28.6% |
| Q2 2020 | $44,272,000 | +6.6% | 360,760 | -23.9% | 0.01% | 0.0% |
| Q1 2020 | $41,521,000 | -0.7% | 474,147 | +18.5% | 0.01% | +16.7% |
| Q4 2019 | $41,834,000 | -0.8% | 400,097 | +9.1% | 0.01% | 0.0% |
| Q3 2019 | $42,191,000 | -34.8% | 366,778 | -2.3% | 0.01% | -40.0% |
| Q2 2019 | $64,687,000 | -11.4% | 375,238 | -13.4% | 0.01% | -9.1% |
| Q1 2019 | $73,007,000 | +53.4% | 433,095 | -11.4% | 0.01% | +37.5% |
| Q4 2018 | $47,604,000 | -45.2% | 488,792 | -2.9% | 0.01% | -42.9% |
| Q3 2018 | $86,936,000 | +35.0% | 503,273 | +9.0% | 0.01% | +27.3% |
| Q2 2018 | $64,417,000 | +12.5% | 461,648 | -9.2% | 0.01% | +10.0% |
| Q1 2018 | $57,285,000 | -15.6% | 508,430 | -1.1% | 0.01% | -9.1% |
| Q4 2017 | $67,882,000 | +14.5% | 514,216 | -11.9% | 0.01% | +22.2% |
| Q3 2017 | $59,260,000 | +1.0% | 583,903 | -0.3% | 0.01% | -25.0% |
| Q2 2017 | $58,688,000 | -21.1% | 585,410 | -4.8% | 0.01% | -20.0% |
| Q1 2017 | $74,348,000 | +1.4% | 614,747 | -6.3% | 0.02% | -6.2% |
| Q4 2016 | $73,341,000 | -22.5% | 656,291 | -7.9% | 0.02% | -23.8% |
| Q3 2016 | $94,606,000 | +29.2% | 712,767 | -10.9% | 0.02% | +23.5% |
| Q2 2016 | $73,242,000 | -1.3% | 799,856 | -22.2% | 0.02% | -5.6% |
| Q1 2016 | $74,187,000 | +23.0% | 1,028,245 | +18.4% | 0.02% | +28.6% |
| Q4 2015 | $60,313,000 | -6.9% | 868,558 | +22.5% | 0.01% | -12.5% |
| Q3 2015 | $64,764,000 | +37.1% | 708,805 | +84.4% | 0.02% | +6.7% |
| Q2 2015 | $47,225,000 | +57.8% | 384,440 | +17.1% | 0.02% | +50.0% |
| Q1 2015 | $29,925,000 | +210.0% | 328,373 | +130.3% | 0.01% | +233.3% |
| Q4 2014 | $9,653,000 | -17.9% | 142,615 | -1.9% | 0.00% | -25.0% |
| Q3 2014 | $11,757,000 | +85.0% | 145,425 | +145.5% | 0.00% | +100.0% |
| Q2 2014 | $6,356,000 | +1501.0% | 59,245 | +785.3% | 0.00% | – |
| Q1 2014 | $397,000 | – | 6,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |